Brainsway(BWAY)
$10.11-0.14 (-1.37%)
BWAY
Brainsway stock drug pipeline
$10.11
At close:-0.14 (-1.37%)
Want to see BWAY full AI Analyst Report?
Brainsway (BWAY) Drug Pipeline
339 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Brainsway Dtms With Intermittent Theta Burst Stimulation (Itbs), Brainsway Dtms With High Frequency (Hf) Stimulation | Major Depressive Disorder | Phase IV | Completed | Brainsway DTMS for Treatment of MDD Using iTBS | Dec 17, 2020 | ― |
| Sham Treatment, Active Dtms Treatment | Smoking Cessation | Phase III | Completed | Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation. | Apr 27, 2014 | ― |
| Deep Transcranial Magnetic Stimulation | Tinnitus | Phase II | Withdrawn | Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus. | Jan 28, 2014 | ― |
| Deep Tms | Machado Joseph Disease (Sca3) | Phase II | Completed | The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease | Dec 29, 2013 | ― |
| Tms | Effect Of Deep Transcranial Magnetic Stimulation On Memory | earlyPhase1 | Withdrawn | Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe | May 07, 2012 | ― |
| H-Coil Deep Tms, Sham Coil Tms | Mild Cognitive Impairment | Phase I | Unknown | Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment | Oct 25, 2011 | ― |
| Transcranial Magnetic Stimulation | Autism | Phase II | Terminated | Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children. | Jun 27, 2011 | ― |
| Treatment By Hlpfc Coil | Attention Deficit Hyperactivity Disorder | Phase I | Unknown | Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults | Sep 07, 2010 | ― |
| Tms, H Coil | Alzheimer's Disease | Phase II | Completed | Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease | Aug 08, 2010 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Brainsway Dtms With Intermittent Theta Burst Stimulation (Itbs), Brainsway Dtms With High Frequency (Hf) Stimulation | Phase IV | Major Depressive Disorder | Completed | Brainsway DTMS for Treatment of MDD Using iTBS | Dec 17, 2020 | ― |
| Sham Treatment, Active Dtms Treatment | Phase III | Smoking Cessation | Completed | Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation. | Apr 27, 2014 | ― |
| Deep Transcranial Magnetic Stimulation | Phase II | Tinnitus | Withdrawn | Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus. | Jan 28, 2014 | ― |
| Deep Tms | Phase II | Machado Joseph Disease (Sca3) | Completed | The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease | Dec 29, 2013 | ― |
| Tms | earlyPhase1 | Effect Of Deep Transcranial Magnetic Stimulation On Memory | Withdrawn | Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe | May 07, 2012 | ― |
| H-Coil Deep Tms, Sham Coil Tms | Phase I | Mild Cognitive Impairment | Unknown | Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment | Oct 25, 2011 | ― |
| Transcranial Magnetic Stimulation | Phase II | Autism | Terminated | Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children. | Jun 27, 2011 | ― |
| Treatment By Hlpfc Coil | Phase I | Attention Deficit Hyperactivity Disorder | Unknown | Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults | Sep 07, 2010 | ― |
| Tms, H Coil | Phase II | Alzheimer's Disease | Completed | Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease | Aug 08, 2010 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Brainsway (BWAY) have in its pipeline
Brainsway BWAY is currently developing the following drugs: Brainsway Dtms With Intermittent Theta Burst Stimulation (Itbs), Brainsway Dtms With High Frequency (Hf) Stimulation, Sham Treatment, Active Dtms Treatment, Deep Transcranial Magnetic Stimulation, Deep Tms, Tms, H-Coil Deep Tms, Sham Coil Tms, Transcranial Magnetic Stimulation, Treatment By Hlpfc Coil, Tms, H Coil. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

